Ara
Toplam kayıt 20, listelenen: 1-10
A Rare Case of Sunitinib-Induced Hyperammonemic Encephalopathy and Hypothyroidism in Metastatic Renal Cell Carcinoma
(LIPPINCOTT WILLIAMS & WILKINS, 2016)
Sunitinib has become a standard treatment agent for metastatic renal cell carcinoma (RCC) for several years. However, various adverse events have been reported. We present a rare adverse effect of hyperammonemic encephalopathy ...
Preoperative Lymphedema-Related Risk Factors in Early-Stage Breast Cancer
(MARY ANN LIEBERT, INC, 2018)
Background: Prolongation of survival in patients with breast cancer due to early diagnosis and modern methods of treatment has turned the attention on lymphedema, which is the most important morbidity secondary to the ...
Can Megestrol Acetate Induce Thrombosis in Advanced Oncology Patients Receiving Chemotherapy?
(ASIAN PACIFIC ORGANIZATION CANCER PREVENTION, 2014)
Background: Megestrol acetate (MA) is a steroid origin medicine often used for control of cachexia in oncologic palliative care. Thrombosis is a common problem in oncology patients. One question is whether MA can cause ...
Does Early PET/CT Assesment of Response to Chemotherapy Predicts Survival in Patients With Advanced Stage Non-Small-Cell Lung Cancer?
(LIPPINCOTT WILLIAMS & WILKINS, 2014)
The aim of this study is to determine the prognostic role and the timing of metabolic response to chemotherapy, based on F-18-fluorodeoxyglucose positron emission tomography (F-18-FDG-PET), in patients with metastatic ...
Stereotactic Vacuum-Assisted Core Biopsy Results for Non-Palpable Breast Lesions
(ASIAN PACIFIC ORGANIZATION CANCER PREVENTION, 2014)
Background: The increase in breast cancer awareness and widespread use of mammographic screening has led to an increased detection of (non-palpable) breast cancers that cannot be discovered through physical examination. ...
Dramatic Response to Catumaxomab Treatment for Malign Ascites Related to Renal Cell Carcinoma With Sarcomotoid Differentiation
(LIPPINCOTT WILLIAMS & WILKINS, 2016)
Refractory malignant ascites (MA) is a common complication in cancer patients. Renal cell carcinoma (RCC) is rarely present with peritoneal ascites, which is commonly associated with carcinomas of the gastrointestinal and ...
Prognostic relevance of sunitinib toxicities and comparison of continuous vs. intermittent sunitinib dosing schedule in metastatic renal cell cancer patients
(TERMEDIA PUBLISHING HOUSE LTD, 2016)
Aim of the study: Sunitinib-related side effects may develop as a result of the pharmacokinetic pathway affects the of the drug. Material and methods: Data on mRCC patients were obtained from the hospital archives. Outcomes ...
Clinical and histopathological factors associated with Ki-67 expression in breast cancer patients
(SPANDIDOS PUBL LTD, 2015)
The aim of the present study was to identify the optimal Ki-67 cut-off value in breast cancer (BC) patients, and investigate the association of Ki-67 expression levels with other prognostic factors. Firstly, a retrospective ...
Bioelectrical Impedance for Detecting and Monitoring Lymphedema in Patients with Breast Cancer. Preliminary Results of the Florence Nightingale Breast Study Group
(MARY ANN LIEBERT, INC, 2015)
The aim of this study was to evaluate the efficacy of bioimpedance spectroscopy for the follow-up of patients with lymphedema in Turkey and its benefits in the diagnosis of stage 0, 1, and 2 lymphedema in patients who are ...
Chronomodulated oxaliplatin plus Capecitabine (XELOX) as a first line chemotherapy in metastatic colorectal cancer: A Phase II Brunch regimen study
(SPRINGER, 2016)
The aim of this study was to evaluate safety and toxicity of chronomodulated capecitabine administered in the morning and at noon according to a specific time schedule (Brunch Regimen: Breakfast and Lunch) as a part of ...